The bill amends the Public Health Code of Michigan by adding a new section, 17748g, which mandates specific labeling requirements for drugs packaged in blister packs. According to the new provision, any drug that is not classified as a controlled substance and is packaged or repackaged by a manufacturer in a blister pack for distribution within the state must have each blister cell, or the backing of the blister pack if there are no perforated cells, clearly labeled with the generic name of the drug.

This legislative change aims to enhance transparency and ensure that consumers and healthcare providers can easily identify the generic name of medications, thereby promoting safer medication practices. The bill does not include any deletions from the current law, focusing solely on the introduction of this new labeling requirement.

Statutes affected:
House Introduced Bill: 333.1101, 333.25211